Skip to content
healthcare.dev

GIVLAARI

NDC 71336-1001, givosiran sodium, injection, solution, from Alnylam Pharmaceuticals, Inc..

Product NDC
71336-1001
Status
Listed
Labeler
Alnylam Pharmaceuticals, Inc.
Dosage form
INJECTION, SOLUTION
Route
SUBCUTANEOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA
Application
NDA212194
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/71336-1001 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • GIVOSIRAN SODIUM189 mg/mL

Pharmacologic classes

Aminolevulinate Synthase 1-directed RNA Interaction [EPC]; Decreased RNA Integrity [PE]; RNA, Small Interfering [CS]; Small Interfering RNA [EPC]

Package NDCNDC-11Package
71336-1001-1713361001011 VIAL, SINGLE-USE in 1 CARTON (71336-1001-1) / 1 mL in 1 VIAL, SINGLE-USE

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/167e663c-11e1-497b-a3fc-951d65d58eaa
  • Medicare Part B payment limits (ASP)

    GET /v1/drugs/asp?ndc=71336-1001

Use it

Look up 71336-1001 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/71336-1001 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 71336-1001. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.